• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Why These 2 Biotech Stocks Made Big Moves Late Thursday

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 13, 2023 at 08:52: PM
via
  • Stock markets kept climbing on Thursday.
  • Acadia stock moved higher as the company expanded a key licensing agreement.
  • Theseus Pharmaceuticals' stock plunged due to the biotech's decision to cease development on a leading candidate treatment.

article source
 




Top Bottom
Back
Quote